In a study based on the European-wide AddNeuroMed/Dementia Case Register biobank repositories (n = 354), a decreasing trend in serum concentrations of serotonin was reported in line with clinical classification, namely the elderly control, mild cognitive impairment and AD ( Whiley et al., 2021 ).
← all excerpts
Genetically predicted circulating levels of glycine, glutamate, and serotonin in relation to the risks of three major neurodegenerative diseases: A Mendelian randomization analysis.
1
—
—